Ruizhi Jiajue

6PUBLICATIONS
22CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 08, 2026
Impact of burosumab on kinetics of intact FGF23 values after the removal of a causative tumor in a patient with tumor-induced osteomalacia.

|Feb 25, 2026
Burosumab for adults with tumor-induced osteomalacia in China.

Ruizhi Jiajue, Chunyan Lu, Jiemei Gu

|Dec 02, 2025
A study on the efficacy and safety of anlotinib in patients with metastatic pheochromocytoma and paraganglioma.

Yunying Cui, Yue Zhou, Wenqian Zhang

|Nov 19, 2021
Bone Impairment in a Large Cohort of Chinese Patients With Tumor-Induced Osteomalacia Assessed by HR-pQCT and TBS.

Xiaolin Ni, Yiming Feng, Wenmin Guan

|May 10, 2021
Early Discrimination Between Tumor-Induced Rickets/Osteomalacia and X-Linked Hypophosphatemia in Chinese Children and Adolescents: A Retrospective Case-Control Study.

Ruizhi Jiajue, Xiaolin Ni, Chenxi Jin

|Apr 09, 2021
Associations between Osteocalcin, Calciotropic Hormones, and Energy Metabolism in a Cohort of Chinese Postmenopausal Women: Peking Vertebral Fracture Study.

Ruizhi Jiajue, Shuying Liu, Yu Pei

Pageof 1

Frequent Collaborators

3 joint publications

Weibo Xia

2 joint publications

Xiang Li

2 joint publications

Yan Jiang

2 joint publications

Mei Li